HKLII Hong Kong Regulations

[Index] [Table] [Search] [Notes] [Noteup] [Previous] [Next] [Download (Current & Past)] [Download (Current only)] [繁體中文] [Help]

PHARMACY AND POISONS REGULATIONS - SCHEDULE 4

STATEMENT OF PARTICULARS AS TO PROPORTION OF POISON IN CERTAIN CASES PERMITTED BY REGULATION 14(a)



[regulation 14]
A
Name of Poison
Particulars
Alkaloids
Aconite, alkaloids of




Belladonna, alkaloids of
Calabar bean, alkaloids of
Coca, alkaloids of
Colchicum, alkaloids of
Ephedra, alkaloids of
Ergot, alkaloids of
Gelsemium, alkaloids of
Lobelia, alkaloids of
Pilocarpus, alkaloids of
Pomegranate, alkaloids of
Quebracho, alkaloids of,
    other than the alkaloids of red quebracho
    Sabadilla, alkaloids of Stavesacre, alkaloids of
Veratrum, alkaloids of
Yohimba, alkaloids of

Antimonial poisons







Arsenical poisons







Digitalis, glycosides of; other active principles of digitalis


Hydrocyanic acid ; cyanides other than ferrocyanides and ferricyanides


Insulin



Lead, compounds of, with acids from fixed oils



Mercury, organic compounds of


Nux Vomica


Opium


Phenols


Compounds of a phenol with a metal




Pituitary gland, the active principles of













Strophanthus, glycosides of





Suprarenal gland, the active principles of; their salts; their derivatives; their salts









Thyroid gland, the active principles of; their salts
The proportion of any one alkaloid of aconite that the preparation would be calculated to contain on the assumption that all the alkaloids of aconite in the preparation were that alkaloid.








The same as above, with the substitution for the reference to aconite of a reference to balladonna, calabar bean or such other of the said poisons as the case may require.








The proportion of antimony trioxide (Sb2O3) or antimony pentoxide (Sb2O5) that the preparation would be calculated to contain on the assumption that the antimony (Sb) in the poison had been wholly converted into antimony trioxide or antimony pentoxide as the case may be.

The proportion of arsenic trioxide (As2O3) or arsenic pentoxide (As2O5) that the preparation would be calculated to contain on the assumption that the arsenic (As) in the poison had been wholly converted into arsenic trioxide or arsenic pentoxide as the case may be.

The number of units of activity as defined in the British Pharmacopoeia contained in a specified quantity of the preparation.

The proportion of hydrocyanic acid (HCN) that the preparation would be calculated to contain on the assumption that the cyanides in the poison had been wholly converted into hydrocyanic acid.

The number of units of activity as defined in the British Pharmacopoeia contained in a specified quantity of the preparation.

The proportion of lead oxide (PbO) that the preparation would be calculated to contain on the assumption that the lead in the poison had been wholly converted into lead oxide.

The proportion of organically-combined mercury (Hg) contained in the preparation.

The proportion of strychnine contained in the preparation.

The proportion of morphine contained in the preparation.

The proportion of phenols (added together) contained in the preparation.

The proportion of phenols (added together) that the preparation would be calculated to contain on the assumption that the compounds of phenols with a metal had been wholly converted into the corresponding phenols.

Either-
    (a) The number of units of activity as defined in the British Pharmacopoeia contained in a specified quantity of the preparation; or
    (b) the proportion of pituitary gland, or of anterior or of posterior lobe of the gland, as the case may be, contained in the preparation; or
    (c) the amount of pituitary gland, or of anterior or of posterior lobe of the gland, as the case may be, from which a specified quantity of the preparation was obtained, together with an indication whether the amount relates to fresh or to dried gland substance.

The amount of Standard Tincture of Strophanthus as defined in the British Pharmacopoeia 1948 which possesses the same activity as a specified quantity of the preparation when assayed by the method described in the said Pharmacopoeia.

Either-
    (a) the proportion of Suprarenal of the cortex or of the medulla of the gland, as the case may be, contained in the preparation; or
    (b) the amount of Suprarenal gland, or of the cortex or of the medulla of the gland, as the case may be, from which a specified quantity of the preparation was obtained, together with an indication whether the amount relates to fresh or to dried gland substance.

Either-
    (a) the proportion of thyroid gland contained in the preparation; or
    (b) the amount of thyroid gland from which a specified quantity of the preparation was obtained together with an indication whether the amount relates to fresh or to dried gland.

B
Barium, salts of The proportion of one particular barium salt which the preparation would be calculated to contain on the assumption that the barium (Ba) in the preparation had been wholly converted into that salt.
Potassium hydroxide The proportion of potassium monoxide (K2O) which the preparation would be calculated to contain on the assumption that the potassium hydroxide in the preparation had been wholly converted into potassium monoxide.
Sodium hydroxide The proportion of sodium monoxide (Na2O) which the preparation would be calculated to contain on the assumption that the sodium hydroxide in the preparation had been wholly converted into sodium monoxide.



[Index] [Table] [Search] [Notes] [Noteup] [Previous] [Next] [Download (Current & Past)] [Download (Current only)] [繁體中文] [Help]